Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2013-09-19 Regulatory Filings
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 95% confidence The document is a press release dated September 19, 2013, announcing the company's participation and presentation schedule at a medical conference (APDW/WCOG 2013). It details scientific presentations, live procedures, and booth presence. This type of announcement, focusing on corporate activities, scientific milestones, or participation in industry events, does not fit the specific financial filing codes (10-K, ER, IR, etc.). It is a general corporate communication. Since it is not a standard regulatory filing like a 10-K or a specific financial event like an earnings release, and it doesn't fit other specific categories like Director's Dealing (DIRS) or Capital Change (CAP), the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general announcement category for non-standard corporate news releases.
2013-09-19 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 90% confidence The document is a press release dated September 19, 2013, announcing the company's strong participation and presentation of new clinical study results (13 new presentations) regarding its Cellvizio optical biopsy technology at the 'Asian Pacific Digestive Week/World Congress of Gastroenterology 2013' (APDW/WCOG 2013). It details clinical utility, quotes management, and mentions live demonstrations. Crucially, it concludes with an announcement for the next press release: 'Prochain communiqué de presse : chiffre d'affaires du T3 2013 le 10 octobre 2013 (post-clôture des marchés)'. This structure—announcing participation in an event, highlighting clinical data, and previewing a future financial report—is characteristic of a general corporate update or news release, not a formal regulatory filing like a 10-K, IR, or ER. Since it is a general corporate announcement about clinical data and participation in a conference, and it is not a specific financial report, management change, or dividend notice, it fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate communication, although it functions like an Investor Presentation (IP) summary, it is framed as a press release about an event. Given the options, RNS is the most appropriate fallback for a general corporate news announcement that doesn't fit the highly specific financial or governance codes.
2013-09-19 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references the French Commercial Code (Article L233-8-II) and the General Regulation of the AMF (Autorité des Marchés Financiers). It provides a table detailing the total number of shares and voting rights as of August 31, 2013. This structure—a mandatory monthly disclosure of total voting rights and share capital—is a specific regulatory filing requirement in France, often categorized under general regulatory announcements or specific share capital updates. Given the options, this is a specific regulatory disclosure concerning the capital structure and voting rights, which is not explicitly covered by codes like 10-K, ER, or DIV. It is closest to a general regulatory filing or a specific capital structure update. Since it is a mandatory, periodic disclosure about the share capital structure and voting rights, it fits best under the general 'Regulatory Filings' (RNS) as a specific type of mandatory disclosure not covered by other specific codes, or potentially 'SHA' (Share Issue/Capital Change), but RNS is a safer fallback for mandatory regulatory updates that aren't earnings or major corporate actions. However, since it is a direct report on the capital structure and voting rights, and not just an announcement of a report, RNS is the most appropriate general regulatory category.
2013-09-06 French
Rapport financier semestriel
Interim / Quarterly Report Classification · 100% confidence The document is a 'Rapport Financier' (Financial Report) for Mauna Kea Technologies for the period ending June 30, 2013. It contains comprehensive financial statements, including the Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, and Cash Flow Statement, along with management commentary and audit information. Since it covers a period shorter than a full fiscal year (a half-year report) and includes substantive financial data, it is classified as an Interim/Quarterly Report. H1 2013
2013-08-30 French
Half yearly financial report
Interim / Quarterly Report Classification · 100% confidence The document is titled 'HALF-YEAR 2013 FINANCIAL REPORT' and contains comprehensive financial statements, including a Statement of Financial Position and a Comprehensive Income Statement for the period ending June 30, 2013. It also includes an activity report and auditor review information. Since it covers a period shorter than a full fiscal year and provides substantive financial data, it is classified as an Interim/Quarterly Report. H1 2013
2013-08-30 English
Communiqués de mise à disposition de documents / Modalités de mise à disposition du rapport financier semestriel
Report Publication Announcement Classification · 99% confidence The document is titled "Mise à disposition du rapport financier semestriel 2013" (Making available of the 2013 semi-annual financial report) and explicitly states that the company has made available and filed its semi-annual financial report for the period ending June 30, 2013, with the financial market authority (AMF). The document itself is very short (2424 characters) and serves primarily to announce the availability of the full report, rather than containing the full report content. This perfectly matches the definition of a Report Publication Announcement (RPA), which is used when a document announces the release of another report, especially given the short length (Rule 2: "MENU VS MEAL" Rule). It is not the Interim/Quarterly Report (IR) itself, but the announcement of it.
2013-08-30 French

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.